Betaxolol
- Generic Name
- Betaxolol
- Brand Names
- Betoptic, Betoptic Pilo, Betoptic S
- Drug Type
- Small Molecule
- Chemical Formula
- C18H29NO3
- CAS Number
- 63659-18-7
- Unique Ingredient Identifier
- O0ZR1R6RZ2
Overview
A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Background
A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Indication
For the management of hypertension.
Associated Conditions
- Hypertension
- Increased Intra Ocular Pressure (IOP)
Clinical Trials
FDA Approved Products
Betaxolol Hydrochloride
Manufacturer:Sandoz Inc
Route:OPHTHALMIC
Strength:5.6 mg in 1 mL
Approved: 2023/10/31
NDC:61314-245
Betoptic S
Manufacturer:Alcon Laboratories, Inc.
Route:OPHTHALMIC
Strength:2.8 mg in 1 mL
Approved: 2023/02/02
NDC:0065-0246
Betaxolol
Manufacturer:Epic Pharma LLC
Route:ORAL
Strength:20 mg in 1 1
Approved: 2019/01/03
NDC:42806-039
Betoptic S
Manufacturer:Novartis Pharmaceuticals Corporation
Route:OPHTHALMIC
Strength:2.8 mg in 1 mL
Approved: 2022/08/03
NDC:0078-0729
BETAXOLOL HYDROCHLORIDE
Manufacturer:KVK-TECH, INC.
Route:ORAL
Strength:20 mg in 1 1
Approved: 2024/02/14
NDC:10702-014
Singapore Approved Products
BETAC FILM COATED TABLET 20 mg
Manufacturer:MEDOCHEMIE LTD - CENTRAL FACTORY, MEDOCHEMIE (FAR EAST) LTD ORAL FACILITY
Form:TABLET, FILM COATED
Strength:20 mg
Online:Yes
Approved: 2004/12/07
Approval:SIN12621P
BETOPTIC S STERILE OPHTHALMIC SUSPENSION 0.25%
Manufacturer:ALCON-COUVREUR NV
Form:SOLUTION
Strength:0.25% w/v
Online:Yes
Approved: 1991/05/18
Approval:SIN05837P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath